Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07692672Phase 3Not yet recruiting
A Phase 3 trial of granulocyte colony-stimulating factor in thin endometrium, female infertility, sponsored by Nanjing University. Planned start Oct 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07692672.